Eminence is a global provider of CDMO services and cell line development, as well as the production of high-quality chemically defined media for CHO, HEK293, and BHK. Eminence's product portfolio includes patented media formulations for biopharmaceuticals, vaccine media, serum, and consumables for cultivation and sample storage. The company ensures data reliability and reproducibility through high levels of quality control and advanced technologies that optimize cell production processes.